Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1966-4-13
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0016-5557
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
581-4
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:4159354-Adult,
pubmed-meshheading:4159354-Aged,
pubmed-meshheading:4159354-Female,
pubmed-meshheading:4159354-Heparinoids,
pubmed-meshheading:4159354-Humans,
pubmed-meshheading:4159354-Intracranial Embolism and Thrombosis,
pubmed-meshheading:4159354-Male,
pubmed-meshheading:4159354-Middle Aged
|
pubmed:year |
1966
|
pubmed:articleTitle |
[2 years of use of synthetic heparinoids in the treatment of cerebral thrombosis].
|
pubmed:publicationType |
Journal Article,
Case Reports
|